piracetam has been researched along with Metabolic Diseases in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zarubina, IV | 1 |
1 other study available for piracetam and Metabolic Diseases
| Article | Year |
|---|---|
Drug correction of behavioral reactions and metabolic disorders in rats with craniocerebral trauma.
Topics: Animals; Antioxidants; Benzimidazoles; Body Weight; Brain; Brain Injuries; Carbon Tetrachloride Pois | 2003 |